SIZE XSSIZE SMSIZE MDSIZE LG

Planning and Review Committee Disclosures 2018

Chahal, Manpreet, PharmD, PhD, Field Medical Director, Breast Cancer, Pfizer: Amgen (A,C)(H): Pfizer (A, SP) (H): Takeda (SP) (H): Lily (A): Incyte (SP) (H)

Curtis-Freitag, Renee, PharmD BCOP, Clinical Pharmacy Manager, Providence Regional Cancer Partnership: No financial relationships exist with commercial interests

Koeller, Jim, MS: Professor, University of Texas Health Science Center: Merck, Takeda (A, SP) (H): Lilly, Pfizer, Eisai (SP) (H): Array (A) (H): Cumberland (C) (H): Helrium (C, SP) (H)

Lombardo, Jeff, PharmD BCOP, Associate Director, Pharmaceutical Sciences, University at Buffalo: Merck (SP) (H)

Malard-Johnson, Darcy, PharmD: Oncology Program Manager, Fairview Pharmacy Services: No financial relationships exist with commercial interests

Marshall, Helen, PharmD BCOP BCPS: Clinical Pharmacist, University of Washington Medical Center: NSCLS with Actionable Mutations, ASHP (H)

McCauley, Dayna, PharmD, BCOP: Oncology Clinical Pharmacist, Good Samaritan Medical Center: No financial relationships exist with commercial interests  

Miller, Tim, PharmD BCOP: Pharmacy Coordinator – Oncology, University of Wisconsin Hospital and Clinics: No financial relationships exist with commercial interests

Reichard, Jeffrey, PharmD BCOP BCPS MS: Director of Pharmacy, Novant Health: No financial relationships exist with commercial interests

Rockey, Michelle, PharmD BCOP: Hematology/Oncology Pharmacy Team Lead, Wake Forest Baptist Health, Juno (A) (H)

Smith-Bondarenka, Carolyn, PharmD BCPS: Manager, Oncology Pharmacy Services, Medical University of South Carolina Medical Center: No financial relationships exist with commercial interests  

Szabatura, Audrea, PharmD BCOP: Medication Safety Officer, Dana Farber Cancer Institute: No financial relationships exist with commercial interests

Thomas, Sonia, PharmD BCOP: Assistant Professor of Pharmacy Practice, Philadelphia College of Osteopathic Medicine: No financial relationships exist with commercial interests  

Valgus, John, PharmD BCOP: Pharmacist, University of North Carolina Hospitals & Clinics: No financial relationships exist with commercial interests  

Verlizzo, Brian, PharmD MHA: Oncology Infusion Manager, Massachusetts General Hospital: The Dedham Group (O) (H)

Ward, Deborah, PharmD BS BSPharm BCOP BCPS: Clinical Pharmacy Specialist, St Jude Children’s Research Hospital: No financial relationships exist with commercial interests  

Whalen, Jeremy, PharmD BCOP: Specialty Clinical Program Director - Oncology at Prime Therapeutics: Prime Therapeutics (E), Merck, Genentech, AstraZeneca (C), Merck, Genentech (H)

Faculty Disclosures

Amerine, Lindsey, PharmD BCPS MS: Associate Director of Pharmacy, University of North Carolina Medical Center, Associate Professor of Clinical Education, UNC Eshelman School of Pharmacy: BD-C (H), Equashield-C (H)

Baker, Nicholas, PharmD BCPS MPH: Regional Pharmacy Services Manager, Northern California Pharmacy Operations, Kaiser Permanente: No financial relationships exist with commercial interests

Earl, Marc, PharmD BCOP: Assistant Director Oncology, Cleveland Clinic: No financial relationships exist with commercial interests

Hansen, Liz, RpH: 340B Specialist Supervisor, Novant Health: No financial relationships exist with commercial interests

Hough, Shannon, PharmD BCOP : Clinical Pharmacist Supervisor, University of Michigan Rogel Cancer Center: Amgen (SH)

Kennerly, Julie, PharmD BCPS MS MHA: Assistant Director of Pharmacy, James Cancer Hospital at the Ohio State University: Jazz, Juno, Pfizer, Seattle Genetics, Tesaro, Lily, Teva (A) (H): Harrison Consulting Group (C) (H)

Koeller, Jim, MS: Professor, University of Texas Health Science Center: Merck, Takeda (A,SP) (H): Lilly, Pfizer, Eisai (SP) (H): Array (A) (H): Cumberland (C) (H): Helrium (C, SP) (H)

Kolodziej, Michael, MD FACP: VP and Chief Innovation Officer, ADVI Health: Aetna (S) ADVI Health (E)

Koth, Sara, PharmD BCOP: Clinical Pharmacist, University of Wisconsin Hospitals and Clinics: No financial relationships exist with commercial interests

Levitt, Jonathan, Esq: Attorney, Frier Levitt: No financial relationships exist with commercial interests  

Macik, Monica, PharmD BCOP BCPS: Clinical Pharmacy Specialist - Hematology/Oncology, Eskenazi Health: No financial relationships exist with commercial interests

Mackler, Emily, PharmD BCOP: Clinical Pharmacist, Hematology/Oncology, Michigan Oncology Quality Consortium: No financial relationships exist with commercial interests

Morales, Paul, PharmD BCOP: Pharmacy Manager, M Health/Fairview Pharmacy Services: No financial relationships exist with commercial interests

Palumbo, Alison, PharmD BCOP: Hematology/Oncology Clinical Pharmacist, Oregon Health and Science University: Oncology Reimbursement Management Advisory Board, National Cancer Institute Physical Data Query Support and Palliative Care (B) (H): Oregon Society Health Systems Pharmacists (SP)(H)

Pick, Amy, PharmD BCOP MOL: Professor, Director of Faculty and Staff Development, Creighton University: No financial relationships exist with commercial interests

Polley,  Stephen PharmD BCPS MPA MS: Pharmacy Manager, Ohio State University Wexner Medical Center: No financial relationships exist with commercial interests

Prevost, Rebecca, PharmD: Manager, Investigational Drug Services and Infusion    Florida Hospital: No financial relationships exist with commercial interests  

Reichard, Jeffrey, PharmD BCOP BCPS MS: Director of Pharmacy, Novant Health: No financial relationships exist with commercial interests

Scott-Rice, Kelly, PharmD: Oncology Pharmacy Navigator, Legacy Cancer Institute: No financial relationships exist with commercial interests

Smith, Alison, PharmD: Pharmacy Manager, University of Kansas Cancer Center: No financial relationships exist with commercial interests

Tyler, Timothy, PharmD FCSHP FHOPA: Director of Pharmacy, Lab & Oncology Supportive Care Services, Comprehensive Cancer Center: Seattle Genetics, Pfizer (C): Bristol Myers Squibb, Genentech, Pfizer, Takeda, Amgen (O) (OB): Corvida Medical (B)(NC)

Key to abbreviations
A‒Advisory Board Member
B‒Board of Directors
C‒Consultant
CEG‒CE-Educational Grant
E‒Employee
EQ‒Equipment (department or practice)
EXR‒Expert Reviewer
EXT‒Expert Testimony
F‒Founder
H‒Honoraria
IC‒Independent Contractor
NC‒No Compensation Received
NCEG   Non-CE Educational Grant
OB‒Other Financial Benefit
OI‒Ownership Interest
PI ‒Principal Investigator
RF‒Research or Fellowship Program Funding
RG‒Research Grant to My Institution
RGP‒Research Grant to My Private Practice
S‒Salary
SH‒Stockholder
SO‒Stock Options
SP‒Speaker Bureau
ST‒Stock

 

 

 

 

Membership

HOPA is an active and engaged organization that provides crucial education, networking, cutting edge resources and advancement opportunities to our members. Find yourself in HOPA. 

Join or renew your membership today!

HOPA and Medscape Oncology Education

HOPA has teamed up with Medscape Oncology Education to provide a series of educational activities designed for pharmacists who specialize in hematology/oncology as well as those who practice in a broader setting and care for patients with cancer less frequently. The collaboration is called Pharmacist Focus on Oncology.

Learn more

Drug Updates

HOPA Events

HOPA Offers Live on Location Educational Events Throughout the Year

Pharmacy Events

(Month View)
logo bcop

HOPA’s BCOP education courses cover the four Domains of Oncology Pharmacy Specialty Practice and improve your knowledge and problem-solving skills in each area. These courses provide BCOP-specific assessments for practicing clinical oncology pharmacists with a need for specific disease prevention and treatment knowledge and strategies.

You can now earn up to 66 hours of BCOP credit through HOPA—the experts in clinical oncology pharmacy. In addition to HOPA’s current BCOP education offerings, HOPA will offer a BCOP Preparatory and Recertification Course being released in 2020. This course is designed for pharmacists preparing to sit for the BCOP Certification Exam as well as those looking to meet the Board of Pharmacy Specialties (BPS) requirement to complete a Preparatory Review/Recertification Course at least once during their recertification cycle. The course will be offering 28 hours of on-demand recertification credit.

Learn More    
 

Latest Discussions

 
xs
sm
md
lg